DMD Simcyp

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jude, A. R.
Right arrow Articles by Radominska-Pandya, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jude, A. R.
Right arrow Articles by Radominska-Pandya, A.

Vol. 29, Issue 5, 652-655, May 2001

13-Hydroxy- and 13-Oxooctadecadienoic acids: Novel Substrates for Human UDP-Glucuronosyltransferases

Anthony R. Jude, Joanna M. Little, Arthur W. Bull, Izabela Podgorski, and Anna Radominska-Pandya

Department of Chemistry, University of Arkansas at Little Rock, Arkansas (A.R.J.); Department of Biochemistry and Molecular Biology, University of Arkansas for Medical Sciences, Little Rock, Arkansas (J.M.L., A.R.-P.); and Department of Chemistry, Oakland University, Rochester, Minnesota (A.W.B., I.P.)

Although there are numerous studies of glucuronidation of endogenous compounds, information on the glucuronidation of fatty acids is lacking. In the present studies, both linoleic acid (LA) and its biologically active oxidized derivatives, 13-hydroxyoctadecadienoic acid (13-HODE) and 13-oxooctadecadienoic acid (13-OXO), have been shown to be effective substrates for human liver UDP-glucuronosyltransferases (UGT) and recombinant UGT2B7. LA (carboxyl glucuronide) and 13-OXO (carboxyl glucuronide, unproven) were actively glucuronidated by human liver microsomes (HLM) and human recombinant UGT2B7 with similar activities, in the range of 2 nmol/mg · min. The hydroxyl derivative of LA, 13-HODE, was glucuronidated at both the hydroxyl and carboxyl functions with carboxyl glucuronidation predominating (ratio of COOH/OH, 2:1). For all substrates, the Km for formation of the carboxyl-linked glucuronide was in the range of 100 to 200 µM while that for the hydroxyl-linked glucuronide was somewhat lower (>100 µM). This is the first demonstration of glucuronidation of LA and its oxidized derivatives, 13-HODE and 13-OXO, by HLM and recombinant UGT2B7.


Copyright © 2001 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
EndocrinologyHome page
S. Chouinard, G. Pelletier, A. Belanger, and O. Barbier
Isoform-Specific Regulation of Uridine Diphosphate-Glucuronosyltransferase 2B Enzymes in the Human Prostate: Differential Consequences for Androgen and Bioactive Lipid Inactivation
Endocrinology, November 1, 2006; 147(11): 5431 - 5442.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
J. M. Little, M. Kurkela, J. Sonka, S. Jantti, R. Ketola, S. Bratton, M. Finel, and A. Radominska-Pandya
Glucuronidation of oxidized fatty acids and prostaglandins B1 and E2 by human hepatic and recombinant UDP-glucuronosyltransferases
J. Lipid Res., September 1, 2004; 45(9): 1694 - 1703.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
C. Girard, O. Barbier, G. Veilleux, M. El-Alfy, and A. Belanger
Human Uridine Diphosphate-Glucuronosyltransferase UGT2B7 Conjugates Mineralocorticoid and Glucocorticoid Metabolites
Endocrinology, June 1, 2003; 144(6): 2659 - 2668.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
D. Turgeon, S. Chouinard, P. Belanger, S. Picard, J.-F. Labbe, P. Borgeat, and A. Belanger
Glucuronidation of arachidonic and linoleic acid metabolites by human UDP-glucuronosyltransferases
J. Lipid Res., June 1, 2003; 44(6): 1182 - 1191.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
L. V. Iyer, M. N. Ho, W. M. Shinn, W. W. Bradford, M. J. Tanga, S. S. Nath, and C. E. Green
Glucuronidation of 1'-Hydroxyestragole (1'-HE) by Human UDP-Glucuronosyltransferases UGT2B7 and UGT1A9
Toxicol. Sci., May 1, 2003; 73(1): 36 - 43.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
O. Barbier, L. Villeneuve, V. Bocher, C. Fontaine, I. P. Torra, C. Duhem, V. Kosykh, J.-C. Fruchart, C. Guillemette, and B. Staels
The UDP-glucuronosyltransferase 1A9 Enzyme Is a Peroxisome Proliferator-activated Receptor alpha and gamma Target Gene
J. Biol. Chem., April 11, 2003; 278(16): 13975 - 13983.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
J. M. Little, L. Williams, J. Xu, and A. Radominska-Pandya
Glucuronidation of the Dietary Fatty Acids, Phytanic Acid and Docosahexaenoic Acid, by Human UDP-Glucuronosyltransferases
Drug Metab. Dispos., May 1, 2002; 30(5): 531 - 533.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2001 by the American Society for Pharmacology and Experimental Therapeutics.